Get the Stockscreener App
2.59
4.86%
0.12
Lisata Therapeutics Inc stock is traded at $2.59, with a volume of 19,732.
It is up +4.86% in the last 24 hours and down -1.89% over the past month.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
See More
Previous Close:
$2.47
Open:
$2.47
24h Volume:
19,732
Relative Volume:
0.61
Market Cap:
$22.68M
Revenue:
-
Net Income/Loss:
$-20.74M
P/E Ratio:
-1.0319
EPS:
-2.51
Net Cash Flow:
$-18.90M
1W Performance:
+2.37%
1M Performance:
-1.89%
6M Performance:
+1.62%
1Y Performance:
-8.48%
1-Day Range:
$2.43
$2.63
1-Week Range:
$2.38
$2.63
52-Week Range:
$1.87
$4.20
Lisata Therapeutics Inc Stock (LSTA) Company Profile
Name
Lisata Therapeutics Inc
Sector
Industry
Phone
908-229-2590
Address
110 ALLEN ROAD, BASKING RIDGE
Compare LSTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LSTA
Lisata Therapeutics Inc
|
2.59 | 21.58M | 0 | -20.74M | -18.90M | -2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Lisata Therapeutics Inc Stock (LSTA) Latest News
Technical signs of recovery in Lisata Therapeutics Inc.2025 Investor Takeaways & Stock Portfolio Risk Management - Newser
Published on: 2025-08-21 04:47:34 - newsyoung.net
Evaluating Lisata Therapeutics Inc. with trendline analysis2025 Top Gainers & Safe Entry Momentum Tips - Newser
Analyzing Lisata Therapeutics Inc. with risk reward ratio charts2025 Earnings Surprises & Fast Momentum Entry Tips - Newser
What’s next for Lisata Therapeutics Inc. stock priceInsider Buying & Accurate Entry/Exit Alerts - Newser
Is It Too Early to Call Recovery in Lisata Therapeutics Inc.2025 Historical Comparison & Real-Time Volume Spike Alerts - thegnnews.com
Top chart patterns to watch in Lisata Therapeutics Inc.Trade Analysis Report & Fast Gain Stock Trading Tips - Newser
Has Lisata Therapeutics Inc. found a price floorJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - Newser
How to interpret RSI for Lisata Therapeutics Inc. stock2025 Support & Resistance & Risk Managed Investment Strategies - Newser
Combining price and volume data for Lisata Therapeutics Inc.Portfolio Value Summary & Low Volatility Stock Suggestions - Newser
Relative strength of Lisata Therapeutics Inc. in sector analysisJuly 2025 Momentum & Accurate Technical Buy Alerts - Newser
Lisata Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Volume & Capital Efficient Trading Techniques - Newser
Visual trend scoring systems applied to Lisata Therapeutics Inc.Inflation Watch & Weekly Stock Breakout Alerts - Newser
Is Lisata Therapeutics Inc. stock ready for a breakout2025 Dividend Review & Growth Focused Entry Point Reports - Newser
What recovery options are there for Lisata Therapeutics Inc.Quarterly Profit Report & Real-Time Volume Analysis - Newser
Should you wait for a breakout in Lisata Therapeutics Inc.July 2025 Fed Impact & Daily Market Momentum Tracking - Newser
Building trade automation scripts for Lisata Therapeutics Inc.July 2025 Volume & Consistent Profit Trading Strategies - Newser
Momentum Traders Eye Lisata Therapeutics Inc. for Quick Bounce2025 Volume Leaders & High Win Rate Trade Tips - 선데이타임즈
Tools to assess Lisata Therapeutics Inc.’s risk profileLong Setup & Consistent Income Trade Ideas - Newser
Backtesting results for Lisata Therapeutics Inc. trading strategies2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Using data models to predict Lisata Therapeutics Inc. stock movementDollar Strength & Community Driven Trade Alerts - Newser
Key External Factors That Drive Lisata Therapeutics Inc. Stock Price Movements2025 Market Overview & Accurate Buy Signal Alerts - Newser
What’s the recovery path for long term holders of Lisata Therapeutics Inc.July 2025 Movers & Safe Entry Point Identification - Newser
Why Lisata Therapeutics Inc. stock attracts strong analyst attentionMarket Growth Review & Pattern Based Trade Signal System - Newser
Strategies to average down on Lisata Therapeutics Inc.2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
Lisata Therapeutics Inc. stock prediction for this weekJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
What MACD signals say about Lisata Therapeutics Inc.Trade Signal Summary & Real-Time Stock Price Movement Reports - Newser
Is Lisata Therapeutics Inc. stock poised for growthJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - Newser
LSTA Q3 EPS Estimate Raised by Brookline Capital Management - Defense World
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth - TipRanks
Lisata Therapeutics Inc Stock (LSTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):